JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TRINER, L.
Right arrow Articles by NAHAS, G. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TRINER, L.
Right arrow Articles by NAHAS, G. G.
Journal of Pharmacology And Experimental Therapeutics, Vol. 153, Issue 3, 569-572, 1966
Copyright © 1966 by American Society for Pharmacology and Experimental Therapeutics


EFFECTS OF THEOPHYLLINE AND CATECHOLAMINES ON LIPOLYSIS AND GLYCOGENOLYSIS IN VIVO

L. TRINER 1 and G. G. NAHAS 1

1 Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, New York

Doses of 45 and 90 mg/kg of theophylline were administered intraperitoneally to rats which were decapitated 40 min later for blood collection; 45 mg/kg produced a slight increase in plasma concentrations of glucose, lactic acid, free fatty acids (FFA) and glycerol, while 90 mg/kg produced a significant increase in concentrations of these substances. In additional experiments, rats first treated with theophylline were also given, 20 min later, epinephrine (E) or norepinephrine (NE) (50 µg/kg intraperitoneally) and sacrificed as previously. E or NE alone did not significantly change FFA or glycerol levels. However, after 45 mg/kg theophylline pretreatment, E or NE administration produced a significant increase in these substances. Theophylline pretreatment also significantly augmented the increase in lactic acid produced by E and, when given with NE, significantly increased glucose, FFA and glycerol concentrations. These results in vivo are consistent with those observed in vitro.

Submitted on December 17, 1965
Accepted on March 17, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics.